GridAI Technologies (GRDX) Retained Earnings (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Retained Earnings came in at $228.6 million in Q4 2025, up 15.14% YoY from $198.5 million in Q4 2024, and little changed on a QoQ basis from $228.4 million in Q3 2025.
GridAI Technologies (GRDX) Retained Earnings (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Retained Earnings data on file, last reported at $228.6 million in Q4 2025.
- Quarterly Retained Earnings rose 15.14% year-over-year to $228.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $228.6 million (up 15.14% YoY) and the FY2025 annual result came in at $228.6 million, up 15.14% from the prior year.
- Retained Earnings held at $228.6 million in Q4 2025, from $228.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $228.6 million in Q4 2025 to a low of -$190.1 million in Q3 2024.
- A 5-year average of -$14.7 million and a median of -$127.5 million in 2021 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings plunged 9191.81% — and 2025, when it soared 220.14%.
- Tracing GRDX's Retained Earnings over 5 years: stood at -$153.9 million in 2021, then decreased by 9.51% to -$168.5 million in 2022, then decreased by 9.37% to -$184.3 million in 2023, then jumped by 207.69% to $198.5 million in 2024, then grew by 15.14% to $228.6 million in 2025.
- The last three Retained Earnings figures came in at $228.6 million (Q4 2025), $228.4 million (Q3 2025), and $198.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 228.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 228.56 Mn |
| Sep 30, 2025 | 228.39 Mn |
| Jun 30, 2025 | 198.35 Mn |
| Mar 31, 2025 | 198.43 Mn |
| Dec 31, 2024 | 198.51 Mn |
| Sep 30, 2024 | -190.10 Mn |
| Jun 30, 2024 | 196.69 Mn |
| Mar 31, 2024 | -178.80 Mn |
| Dec 31, 2023 | -184.33 Mn |
| Sep 30, 2023 | 183.51 Mn |
| Jun 30, 2023 | 177.68 Mn |
| Mar 31, 2023 | -172.60 Mn |
| Dec 31, 2022 | -168.53 Mn |
| Sep 30, 2022 | -164.50 Mn |
| Jun 30, 2022 | -168.94 Mn |
| Mar 31, 2022 | -163.53 Mn |
| Dec 31, 2021 | -153.90 Mn |
| Sep 30, 2021 | -142.73 Mn |
| Jun 30, 2021 | -112.33 Mn |
| Mar 31, 2021 | -103.05 Mn |